Drug interactions and adverse drug reactions in the older patients admitted to the emergency department

Acta Clinica Belgica

Volumn 68, Issue 1, 2013, Pages 15-21

  De Paepe, P ^a,b   Petrovic, M ^a,b   Outtier, L ^a   Van Maele, G ^c   Buylaert, W ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Adverse drug reactions; Drug interactions; Emergency department; Older patients

Indexed keywords

ALLOPURINOL; AMOXICILLIN; ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLINERGIC RECEPTOR BLOCKING AGENT; COUMARIN ANTICOAGULANT; DIGITALIS GLYCOSIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LEVODOPA; MOLSIDOMINE; NEUROLEPTIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SALICYLIC ACID DERIVATIVE;

AGE; AGED; ALLERGIC REACTION; ANEMIA; ARTICLE; BLEEDING; BRADYCARDIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFUSION; DIARRHEA; DRUG SURVEILLANCE PROGRAM; EDEMA; ELECTROLYTE DISTURBANCE; EMERGENCY WARD; FAINTNESS; FATIGUE; FEMALE; GASTROINTESTINAL OBSTRUCTION; GENDER; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; KIDNEY FAILURE; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; ORTHOSTATIC HYPOTENSION; RISK FACTOR; SIDE EFFECT; VOMITING; BELGIUM; DRUG INTERACTION; DRUG TOXICITY; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; POLYPHARMACY; PROSPECTIVE STUDY; SEX RATIO; STATISTICAL MODEL; STATISTICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BELGIUM; DRUG INTERACTIONS; DRUG TOXICITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; POLYPHARMACY; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

MLCS; MLOWN;

EID: 84879542483     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.2143/ACB.68.1.2062714     Document Type: Article

References (61)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205
2. Hohl CM, Dankoff J, Colacone A, Afilala M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001; 38: 666-671
3. Raschetti R, Morgutti M, Menniti-Ippolito F, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999; 54: 959-963
4. Tafreshi MJ, Melby MJ, Kaback KR, Nord TC. Medication-related visits to the emergency department: A prospective study. Ann Pharmacother 1999; 33: 1252-1257
5. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admissions in the elderly. Intern Med J 2001; 31: 199-205
6. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27: 832-840
7. Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery PR. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988; 36: 1092-1098
8. Wu TY, Jen MH, Bottle A, Molokhia M, Aylin P, Bell D, Majeed A. Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009. J R Soc Med 2010; 103: 239-250
9. Edwards IR, Aronson JK. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 2000; 356: 1255-1259
10. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245
11. Hallas J, Haghfelt T, Gram LF, Grodum E, Damsbo N. Drug related admissions to a cardiology department; frequency and avoidability. J Intern Med 1990; 228: 379-384
12. British National Formulary (September 2008). Interactions. BMJ Group, London
13. Mura P. Éviter les effets indésirables par interactions médicamenteuses. Comprendre et décider. La Revue prescrire 2008; 28: 1-288
14. Hansten PD, Horn JR. In: Wolters Kluwers Health, Inc., ed. Managing clinically important drug interactions. Facts and Comparisons. St. Louis 2003
15. Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 2007; 41: 674-680
16. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-543
17. Malhotra S, Karan RS, Pandhi P, Jain S. Drug related medical emergencies in the elderly: Role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703-707
18. Dennehy CE, Kishi DT, Louie C. Drug-related illness in emergency department patients. Am J Health Syst Pharm 1996; 53: 1422-1426
19. Wasserfallen J, Livio F, Buclin T, Tillet L, Yersin B, Biollaz J. Rate, type, and cost of adverse drug reactions in emergency department admissions. Eur J Pharmacol 2001; 12: 442-447
20. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18820 patients. BMJ 2004; 329: 15-19
21. Hohl CM, Robitaille C, Lord V, et al. Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department. Acad Emerg Med 2005; 12: 197-205
22. Budnitz DS, Pollock DA, Mendelsohn AB, Weidenbach KN, McDonald AK, Annest JL. Emergency department visits for outpatient adverse drug events: Demonstration for a national surveillance system. Ann Emerg Med 2005; 45: 197-206
23. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006; 296: 1858-1866
24. Queneau P, Bannwarth B, Carpentier F, et al. Emergency department visits caused by adverse drug events: Results of a French survey. Drug Saf 2007; 30: 81-88
25. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: Inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767-777
26. Stoukides CA, D?Agostino PR, Kaufman MB. Adverse drug reaction surveillance in an emergency room. Am J Hosp Pharm 1993; 50: 712-714
27. Schneitman-McIntyre O, Farnen TA, Gordon N, Chan J, Toy WA. Medication misadventures resulting in emergency department visits at an HMO medical center. Am J Health Syst Pharm 1996; 53: 1416-1421
28. Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: A prospective study. CMAJ 2008; 178: 1563-1569
29. Yee JL, Hasson NK, Schreiber DH. Drug-related emergency department visits in an elderly veteran population. Ann Pharmacother 2005; 39: 1990-1995
30. Hohl CM, Zed PJ, Brubacher JR, Abu-Laban RB, Loewen PS, Purssell RA. Do emergency physicians attribute drug-related emergency department visits to medication-related problems Ann Emerg Med 2010; 55: 493-502
31. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier Extra 2002: 1-16
32. Leendertse AJ, Egberts AC, Stoker LJ, Van Den Bernt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168: 1890-1896
33. Verhaeghe W, Mets T, Corne L. Benzodiazepine use among elderly patients presenting at the emergency room. Arch Gerontol Geriatr 1996; 22: 55-62
34. Demarest S, Gisle L, Hesse E, Miermans PJ, Tafforeau J, Van Der Heyden J. Health survey Belgium 2004. IPH/EPI reports n° 2006 - 037. Available via http://www.iph.fgov.be/epidemio/epinl/crospnl/hisnl/his04nl/hisnl.pdf. Accessed October 24, 2011
35. Tran C, Knowles SR, Liu BA, Shear NH. Gender differences in adverse drug reactions. J Clin Pharmacol 1998; 38: 1003-1009
36. Bowman L, Carlstedt BC, Hancock EF, Black CD. Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatients. Pharmacoepidemiol Drug Saf 1996; 5: 9-18
37. Montastruc JL, Lapeyre-Mestre M, Bagheri H, Fooladi A. Gender differences in adverse drug reactions: Analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France. Fund Clin Pharmacol 2002; 16: 343-346
38. Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients J Am Geriatr Soc 1991; 39: 1093-1099
39. Bégaud B, Martin K, Fourrier A, Haramburu F. Does age increase the risk of adverse drug reactions Br J Clin Pharmacol 2002; 54: 548-552
40. Karas S Jr. The potential for drug interactions. Ann Emerg Med 1981; 10: 627-630
41. Herr RD, Caravati EM, Tyler LS, Iorg E, Linscott MS. Prospective evaluation of adverse drug interactions in the emergency department. Ann Emerg Med 1992; 21: 1331-1334
42. Beers MH, Storrie M, Lee G. Potential adverse drug interactions in the emergency room. An issue in the quality of care. Ann Intern Med 1990; 112: 61-64
43. Nixdorff N, Hustey FM, Brady AK, Vaji K, Leonard M, Messinger-Rapport BJ. Potentially inappropriate medications and adverse drug effects in elders in the emergency department. Am J Emerg Med 2008; 26: 697-700
44. Prybys K. Deadly drug interactions in emergency medicine. Emerg Med Clin N Am 2004; 22: 845-863
45. Gaeta T, Fiorini M, Ender K, Bove J, Diaz J. Potential drug-drug interactions in elderly patients presenting with syncope. J Emerg Med 2002; 22: 159-162
46. Leape LL, Brennan TA, Laird N et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377-384
47. Gaddis GM, Holt TR, Woods M. Drug interactions in at-risk emergency department patients. Acad Emerg Med 2002; 9: 1162-1167
48. Multidisciplinary Medication Management Project (2001). Top ten dangerous drug interactions in long-term care. Available via http://www.amda.com/tools/ clinical/m3/topten.cfm. Accessed October 24, 2011
49. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population. Am J Emerg Med 1996; 14: 447-450
50. Heininger-Rothbucher D, Bischinger S, Ulmer H, Pechlaner C, Speer G, Wiedermann CJ. Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation 2001; 49: 283-288
51. Howard RL, Avery AJ, Howard PD, Patridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: Observational study. Qual Saf Health Care 2003; 12: 280-285
52. Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Ann Pharmacother 2002; 36: 1238-1248
53. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: Prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000; 56: 181-186
54. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007; 370: 185-191
55. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: How well can it be measured and optimised Lancet 2007; 370: 173-184
56. Spinewine A. Adverse Drug Reactions in Elderly People: The challenge of safer prescribing. BMJ 2008; 336: 956-957
57. Langdorf MI, Fox JC, Marwah RS, Montague BJ, Hart MM. Physician versus computer knowledge of potential drug interactions in the emergency department. Acad Emerg Med 2000; 7: 1321-329
58. Rigby D. Collaboration between doctors and pharmacists in the community. Aust Prescr 2010; 33: 191-193
59. Collignon U, Oborne CA, Kostrzewski. Pharmacy services to UK emergency departments: A descriptive study. Pharm World Sci 2010; 32: 90-96
60. Glasgow RE, Emmons KM. How can we increase translation of research into practice Types of evidence needed. Annu Rev Public Health 2007; 28: 413-433
61. Glaser J, Rolita L. Educating the older adult in over-the-counter medication use. Geriatrics and Aging 2009; 12: 103-109.